Akebia Therapeutics, Inc. drugs

2 results

Auryxia (ferric citrate)

(ferric citrate)
Akebia Therapeutics, Inc.
Usage: Auryxia is indicated for controlling serum phosphorus levels in adults with chronic kidney disease on dialysis and for treating iron deficiency anemia in adults with chronic kidney disease not on dialysis.
Akebia Therapeutics, Inc.
Usage: VAFSEO is indicated for treating anemia in adults with chronic kidney disease who have been on dialysis for at least three months. It is not approved for improving quality of life or for patients not on dialysis. It should not replace red blood cell transfusions for urgent anemia correction.